Literature DB >> 22972972

Radiotherapy physics research in the UK: challenges and proposed solutions.

R I Mackay1, N G Burnet, S Green, T M Illidge, J N Staffurth.   

Abstract

In 2011, the Clinical and Translational Radiotherapy Research Working Group (CTRad) of the National Cancer Research Institute brought together UK radiotherapy physics leaders for a think tank meeting. Following a format that CTRad had previously and successfully used with clinical oncologists, 23 departments were asked to complete a pre-meeting evaluation of their radiotherapy physics research infrastructure and the strengths, weaknesses, opportunities and threats within their own centre. These departments were brought together with the CTRad Executive Group and research funders to discuss the current state of radiotherapy physics research, perceived barriers and possible solutions. In this Commentary, we summarise the submitted materials, presentations and discussions from the meeting and propose an action plan. It is clear that there are challenges in both funding and staffing of radiotherapy physics research. Programme and project funding streams sometimes struggle to cater for physics-led work, and increased representation on research funding bodies would be valuable. Career paths for academic radiotherapy physicists need to be examined and an academic training route identified within Modernising Scientific Careers; the introduction of formal job plans may allow greater protection of research time, and should be considered. Improved access to research facilities, including research linear accelerators, would enhance research activity and pass on developments to patients more quickly; research infrastructure could be benchmarked against centres in the UK and abroad. UK National Health Service departments wishing to undertake radiotherapy research, with its attendant added value for patients, need to develop a strategy with their partner higher education institution, and collaboration between departments may provide enhanced opportunities for funded research.

Entities:  

Mesh:

Year:  2012        PMID: 22972972      PMCID: PMC3474027          DOI: 10.1259/bjr/61530686

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  17 in total

1.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Authors:  David Dearnaley; Isabel Syndikus; Georges Sumo; Margaret Bidmead; David Bloomfield; Catharine Clark; Annie Gao; Shama Hassan; Alan Horwich; Robert Huddart; Vincent Khoo; Peter Kirkbride; Helen Mayles; Philip Mayles; Olivia Naismith; Chris Parker; Helen Patterson; Martin Russell; Christopher Scrase; Chris South; John Staffurth; Emma Hall
Journal:  Lancet Oncol       Date:  2011-12-12       Impact factor: 41.316

2.  Radiotherapy research priorities for the UK.

Authors:  T S Maughan; T M Illidge; P Hoskin; W G McKenna; T B Brunner; I J Stratford; K J Harrington; R Plummer; L J Billingham; C Nutting; N G Burnet; R I Mackay; A Oliver; C Young; C S K Chan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-02       Impact factor: 4.126

3.  Best research for best health: a new national health research strategy.

Authors:  Timothy W Evans
Journal:  Clin Med (Lond)       Date:  2006 Sep-Oct       Impact factor: 2.659

4.  A new opportunity for radiotherapy research in the UK.

Authors:  T S Maughan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-01-24       Impact factor: 4.126

5.  Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.

Authors:  Lester J Peters; Brian O'Sullivan; Jordi Giralt; Thomas J Fitzgerald; Andy Trotti; Jacques Bernier; Jean Bourhis; Kally Yuen; Richard Fisher; Danny Rischin
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

Review 6.  Survey of the availability and use of advanced radiotherapy technology in the UK.

Authors:  W P M Mayles
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-07-27       Impact factor: 4.126

7.  Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

Authors:  P Price; P J Hoskin; D Easton; D Austin; S G Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1986-08       Impact factor: 6.280

8.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.

Authors:  D P Dearnaley; V S Khoo; A R Norman; L Meyer; A Nahum; D Tait; J Yarnold; A Horwich
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

Review 9.  Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities.

Authors:  John Yarnold; Søren M Bentzen; Charlotte Coles; Joanne Haviland
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

10.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet       Date:  2008-03-19       Impact factor: 79.321

View more
  3 in total

1.  Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Authors:  Catharine H Clark; Edwin G A Aird; Steve Bolton; Elizabeth A Miles; Andrew Nisbet; Julia A D Snaith; Russell A S Thomas; Karen Venables; David I Thwaites
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

2.  Variations in Demand across England for the Magnetic Resonance-Linac Technology, Simulated Utilising Local-level Demographic and Cancer Data in the Malthus Project.

Authors:  T Mee; A J Vickers; R Jena; K J Kirkby; A Choudhury; N F Kirkby
Journal:  Clin Oncol (R Coll Radiol)       Date:  2021-03-26       Impact factor: 4.925

3.  Radiation therapists' perspectives on participating in research.

Authors:  Georgia K B Halkett; Melissa Berg; Martin A Ebert; David Cutt; Michael Davis; Desley Hegney; Michael House; Michelle Judson; Rachel Kearvell; Michele Krawiec; Leanne Lester; Sharon Maresse; Peter McLoone; Jan McKay
Journal:  J Med Radiat Sci       Date:  2017-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.